Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum — Stella

Recruiting

Back to Emphysema trials

Trial locations(1 site)

Canada

Firestone Institute for Respiratory Health, St. Joseph's Healthcare, Hamilton, Ontario

Key details

Sponsor

McMaster University

Collaborators

Foresee Pharmaceuticals Co., Ltd.

Enrollment target

~45 participants

Started

November 2022

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

40 Years – 85 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov